Neurocrine Biosciences Research and Development Expenses 2010-2025 | NBIX
Neurocrine Biosciences research and development expenses for the twelve months ending March 31, 2025 were $0.835B, a 42.74% increase year-over-year.
- Neurocrine Biosciences annual research and development expenses for 2024 were $0.731B, a 29.4% increase from 2023.
- Neurocrine Biosciences annual research and development expenses for 2023 were $0.565B, a 21.82% increase from 2022.
- Neurocrine Biosciences annual research and development expenses for 2022 were $0.464B, a 41.36% increase from 2021.